Burkina Faso vs Kenya: Population requiring preventive chemotherapy for schistosomiasis
Burkina Faso
4.46 million
in 2024
Kenya
4.77 million
in 2024
Burkina Faso rank
19th
Kenya rank
18th
Population requiring preventive chemotherapy for schistosomiasis over time
- Burkina Faso
- Kenya
How they compare
Kenya currently reports 4.77 million against 4.46 million in Burkina Faso, a difference of 303,240.
That makes Kenya's figure about 1.1 times Burkina Faso's.
The two have swapped places 4 times across 15 shared years of data; in 2010 it was Kenya ahead.
Burkina Faso ranks 19th and Kenya ranks 18th of 52 countries.
Kenya has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Burkina Faso | Kenya | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3.88 million | 6.35 million | 2.47 million | Kenya |
| 2020s | 3.48 million | 4.24 million | 759,116 | Kenya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Burkina Faso or Kenya?
- Kenya, at 4.77 million against 4.46 million in Burkina Faso as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Burkina Faso and Kenya?
- 303,240, with Kenya ahead.
- How many years of comparable data are there for Burkina Faso and Kenya?
- 15 years are reported by both, from 2010 to 2024.
- How do Burkina Faso and Kenya rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Burkina Faso ranks 19th and Kenya ranks 18th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.